(LPCN) |
| 0 (0%) 10-27 11:38 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 3.15 |
| Resistance 1: | 2.48 |
| Pivot price: | 1.64 |
| Support 1: | 1.40 |
| Support 2: | 1.16 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -12510000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -173.750 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 495.1 |
| Return on Equity (ttm) | -37.0 |
Company news
Thu, 08 Oct 2026
Here's Why You Should Add LPCN Stock to Your Portfolio Now - Yahoo Finance
Wed, 07 Oct 2026
LPCN Stock Pops As BLOOM Phase 3 Trial Kicks Off - Timothy Sykes
Wed, 07 Oct 2026
LPCN Stock Is Surging: Here’s Why Lipocine Is On Traders’ Radar Today - Yahoo Finance
Wed, 07 Oct 2026
Morning Market Movers: BIYA, LPCN, SXTC, BULL See Big Swings - RTTNews
Tue, 15 Sep 2026
Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression - Psychiatric Times
Mon, 14 Sep 2026
Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
